The Latest Breaking News on Pharma

The healthcare industry is expected to witness robust growth driven by increased demand for medicines. Therefore, small-cap Wall Street healthcare favorites Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and Equillium (EQ) might be ideal additions to your portfolio. Keep reading….

A unanimous Supreme Court ruling means the abortion pill mifepristone remains available, including via mail delivery

Supreme Court ruling on FDA's mifepristone regulations post-Dobbs v. Jackson Women’s Health Organization overturning Roe v. Wade, emphasizing engagement in...

Supreme Court rejected conservative group’s attempt to restrict access to abortion pill medication but left the door open for further lawsuits

Sarepta stock jumped Thursday after Pfizer's rival gene therapy for Duchenne muscular dystrophy failed in final-phase testing.

There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.

Regeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug, Dupixent, in COPD treatment.

Eli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's treatment, donanemab.

These five companies may offer higher earnings and return potential with lower risk. Two Leaderboard stocks included.

The biotech sector is primed for robust expansion fueled by the growing needs for personalized medicines and favorable government initiatives. Amid this backdrop, investors could consider buying biotech stocks Esperion Therapeutics (ESPR), Corcept Therapeutics (CORT), and Shionogi (SGIOY). Keep reading.

The share price recovery has been partly driven by the surge in wholesale energy prices, which is beyond his control